Filing Details
- Accession Number:
- 0001209191-22-003820
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-01-19 18:43:51
- Reporting Period:
- 2022-01-14
- Accepted Time:
- 2022-01-19 18:43:51
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1178879 | Amicus Therapeutics Inc. | FOLD | Pharmaceutical Preparations (2834) | 200422823 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1400973 | F John Crowley | C/O Amicus Therapeutics, Inc. 3675 Market Street Philadelphia PA 19104 | Chairman & Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2022-01-14 | 239,099 | $0.00 | 894,230 | No | 4 | A | Direct | |
| Common Stock | Acquisiton | 2022-01-14 | 149,660 | $0.00 | 1,043,890 | No | 4 | A | Direct | |
| Common Stock | Disposition | 2022-01-14 | 58,891 | $10.53 | 984,999 | No | 4 | F | Direct | |
| Common Stock | Disposition | 2022-01-18 | 8,564 | $10.23 | 976,435 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | A | Direct | |
| No | 4 | A | Direct | |
| No | 4 | F | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Options (right to buy) | Acquisiton | 2022-01-14 | 438,222 | $0.00 | 438,222 | $12.11 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 438,222 | 2032-01-14 | No | 4 | A | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 64,895 | Indirect | By Trust |
Footnotes
- Granted in the form of Restricted Stock Units. Each Restricted Stock Unit represents a contingent right to receive one share of Amicus common stock.
- The Restricted Stock Units will vest in four equal annual installments beginning on January 3, 2023.
- Granted for the achievement of the 2019 PRSU TSR goal as determined by the Board of Directors.
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
- These options vest and become exercisable in a series of installments over a four year period, with 25% vesting on January 3, 2023 and the remaining 75% vesting ratably each month thereafter.
Billionaire Hedge Funds
